Attenuation of portal hypertension by continuous portal infusion of PGE1 and immunologic impact in adult-to-adult living-donor liver transplantation

Transplantation

Volumn 95, Issue 12, 2013, Pages 1521-1527

  Onoe, Takashi ^a,b   Tanaka, Yuka ^a   Ide, Kentaro ^a   Ishiyama, Kouhei ^a   Oshita, Akihiko ^a   Kobayashi, Tsuyoshi ^a   Amano, Hironobu ^a   Tashiro, Hirotaka ^a   Ohdan, Hideki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Alloimmune response; Living donor liver transplantation; Portal hypertension; Prostaglandin E1; Small for size graft

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; PROSTAGLANDIN E1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; GRAFT DYSFUNCTION; GRAFT REJECTION; HUMAN; HYPERAMMONEMIA; HYPERBILIRUBINEMIA; IMMUNE RESPONSE; LIVER FUNCTION TEST; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MIXED LYMPHOCYTE REACTION; OVERALL SURVIVAL; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL FOR SIZE GRAFT; SMALL FOR SIZE SYNDROME;

ALPROSTADIL; FEMALE; FLUORESCEINS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERTENSION, PORTAL; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PORTAL PRESSURE; PROGNOSIS; REPERFUSION; SUCCINIMIDES; TREATMENT OUTCOME;

EID: 84880132043     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829150a4     Document Type: Article

References (38)

1. Gonzalez HD, Liu ZW, Cashman S, et al. Small for size syndrome following living donor and split liver transplantation. World J Gastrointest Surg 2010; 2: 389.
2. Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005; 5: 2605.
3. Smyrniotis V, Kostopanagiotou G, Kondi A, et al. Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int 2002; 15: 355.
4. Yagi S, Iida T, Taniguchi K, et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl 2005; 11: 68.
5. Man K, Fan ST, Lo CM, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003; 237: 256.
6. Ogura Y, Hori T, El Moghazy WM, et al. Portal pressure G15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl 2010; 16: 718.
7. Botha JF, Langnas AN, Campos BD, et al. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl 2010; 16: 649.
8. Asakura T, Ohkohchi N, Orii T, et al. Portal vein pressure is the key for successful liver transplantation of an extremely small graft in the pig model. Transpl Int 2003; 16: 376.
9. Mitsuta H, Ohdan H, Fudaba Y, et al. Near-infrared spectroscopic analysis of hemodynamics and mitochondrial redox in right lobe grafts in living-donor liver transplantation. Am J Transplant 2006; 6: 797.
10. Tashiro H, Ohdan H, Itamoto T, et al. Using recipient's middle hepatic vein for drainage of the right paramedian sector in right liver graft. Transplantation 2008; 86: 1565.
11. Chen Z, Yan L, Li B, et al. Prevent small-for-size syndrome using dual grafts in living donor liver transplantation. J Surg Res 2009; 155: 261.
12. Song GW, Lee SG, Hwang S, et al. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier. Liver Transpl 2010; 16: 491.
13. Boillot O, Delafosse B, Mechet I, et al. Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet 2002; 359: 406.
14. Troisi R, Ricciardi S, Smeets P, et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant 2005; 5: 1397.
15. Shimada M, Ijichi H, Yonemura Y, et al. The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology 2004; 51: 625.
16. Umeda Y, Yagi T, Sadamori H, et al. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 2008; 86: 673.
17. Yoshizumi T, Taketomi A, Soejima Y, et al. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int 2008; 21: 833.
18. Balci D, Taner B, Dayangac M, et al. Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report. Transplant Proc 2008; 40: 1786.
19. Samimi F, Irish WD, Eghtesad B, et al. Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci 1998; 43: 1931.
20. Neumann UP, Langrehr JM, Kaisers U, et al. Simultaneous splenec-tomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transpl Int 2002; 15: 226.
21. Iwata K, Shimazu M, Wakabayashi G, et al. Intraportal perfusion of prostaglandin E1 attenuates hepatic postischaemic microcirculatory impairments in rats. J Gastroenterol Hepatol 1999; 14: 634.
22. Asanuma Y, Sato T, Kato T, et al. Continuous arterial infusion of prostaglandin E(1) via the superior mesenteric artery in the treatment of postoperative liver failure. Ther Apher 2002; 6: 89.
23. Paramore CG, Turner DA, Madison RD. Fluorescent labeling of dissociated fetal cells for tissue culture. J Neurosci Methods 1992; 44: 7.
24. Tanaka Y, Ohdan H, Onoe T, et al. Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 2005; 79: 1262.
25. Dirsch O, Li J, He Q, et al. Induction of rejection after small-for-size liver transplantation: size matters. J Invest Surg 2008; 21: 288.
26. Onoe T, Ohdan H, Tokita D, et al. Liver sinusoidal endothelial cells have a capacity for inducing nonresponsiveness of T cells across major histocompatibility complex barriers. Transpl Int 2005; 18: 206.
27. Onoe T, Ohdan H, Tokita D, et al. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J Immunol 2005; 175: 139.
28. Tokita D, Shishida M, Ohdan H, et al. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity. J Immunol 2006; 177: 3615.
29. Matsuo K, Togo S, Sekido H, et al. Pharmacologic preconditioning effects: prostaglandin E1 induces heat-shock proteins immediately after ischemia/reperfusion of the mouse liver. J Gastrointest Surg 2005; 9: 758.
30. Natori S, Fujii Y, Kurosawa H, et al. Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 1997; 64: 1514.
31. Assaad A. Posttransplantation management of the newborn and the immunosuppressive role of prostaglandin E1. J Heart Lung Transplant 1993; 12: S191.
32. Campbell D Jr, Wiggins R, Kunkel S, et al. Constant intrarenal infusion of PGE1 into a canine renal transplant using a totally implantable pump. Transplantation 1984; 38: 209.
33. Yang H, Majno P, Morel P, et al. Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 2002; 64: 94.
34. Ohdan H, Mizunuma K, Tashiro H, et al. Intraoperative near-infrared spectroscopy for evaluating hepatic venous outflow in living-donor right lobe liver. Transplantation 2003; 76: 791.
35. Ohdan H, Tashiro H, Ishiyama K, et al. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system. Transpl Int 2007; 20: 970.
36. Kawaguchi Y, Tashiro H, Amano H, et al. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari syndrome secondary to essential thrombocythemia. Hepatol Res 2009; 39: 520.
37. Tanaka Y, Ohdan H, Onoe T, et al. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol Invest 2004; 33: 309.
38. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997; 100: 3173.